The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3449-3452

  Heubner, Martin ^a   Wimberger, Pauline ^a   Kasimir Bauer, Sabine ^a   Otterbach, Friedrich ^a   Kimmig, Rainer ^a   Siffert, Winfried ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

L1C; L1CAM; Ovarian cancer; Polymorphism; SNP

Indexed keywords

CELL ADHESION MOLECULE; DNA FRAGMENT; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, SEROUS; DINUCLEOTIDE REPEATS; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NEURAL CELL ADHESION MOLECULE L1; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 68549110300     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Li G, Satyamoorthy K and Herlyn M: Dynamics of cell interactions and communications during melanoma development. Crit Rev Oral Biol Med 13: 62-70, 2002. (Pubitemid 34792761)
2. Davis JQ and Bennett V: Ankyrin binding activity shared by the neurofascin/L1/NrCAM family of nervous system cell adhesion molecules. J Biol Chem 269: 27163-27166, 1994.
3. MacFarlane JR, Du JS, Pepys ME, Ramsden S, Donnai D, Charlton R, Garrett C, Tolmie J, Yates JR, Berry C, Goudie D, Moncla A, Lunt P, Hodgson S, Jouet M and Kenwrick S: Nine novel L1 CAM mutations in families with X-linked hydrocephalus. Hum Mutat 9: 512-518, 1997. (Pubitemid 27250814)
4. De Angelis E, MacFarlane J, Du JS, Yeo G, Hicks R, Rathjen FG, Kenwrick S and Brummendorf T: Pathological missense mutations of neural cell adhesion molecule L1 affect homophilic and heterophilic binding activities. EMBO J 18: 4744-4753, 1999. (Pubitemid 29415528)
5. Moos M, Tacke R, Scherer H, Teplow D, Fruh K and Schachner M: Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334: 701-703, 1988. (Pubitemid 18197567)
6. Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, Sanderson MP, Arlt M, Moldenhauer G, Fogel M, Kruger A and Altevogt P: The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 27: 1281-1289, 2008. (Pubitemid 351294696)
7. Schuch U, Lohse MJ and Schachner M: Neural cell adhesion molecules influence second messenger systems. Neuron 3: 13-20, 1989.
8. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M and Montgomery AM: Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 279: 28880-28888, 2004. (Pubitemid 38915755)
9. Buchstaller A, Kunz S, Berger P, Kunz B, Ziegler U, Rader C and Sonderegger P: Cell adhesion molecules NgCAM and axonin-1 form heterodimers in the neuronal membrane and cooperate in neurite outgrowth promotion. J Cell Biol 135: 1593-1607, 1996. (Pubitemid 26427654)
10. Hall H, Djonov V, Ehrbar M, Hoechli M and Hubbell JA: Heterophilic interactions between cell adhesion molecule L1 and αvβ3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis 7: 213-223, 2004.
11. Senner V, Kismann E, Puttmann S, Hoess N, Baur I and Paulus W: L1 expressed by glioma cells promotes adhesion but not migration. Glia 38: 146-154, 2002. (Pubitemid 34896217)
12. Thies A, Schachner M, Moll I, Berger J, Schulze HJ, Brunner G and Schumacher U: Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 38: 1708-1716, 2002. (Pubitemid 34886511)
13. Fogel M, Mechtersheimer S, Huszar M, Smirnov A, bu-Dahi A, Tilgen W, Reichrath J, Georg T, Altevogt P and Gutwein P: L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett 189: 237-247, 2003.
14. Arlt MJ, Novak-Hofer I, Gast D, Gschwend V, Moldenhauer G, Grunberg J, Honer M, Schubiger PA, Altevogt P and Kruger A: Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 66: 936-943, 2006 (Pubitemid 43165961)
15. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, Edler L, Ben-Arie A, Huszar M and Altevogt P: L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362: 869-875, 2003. (Pubitemid 37130096)
16. Zecchini S, Bianchi M, Colombo N, Fasani R, Goisis G, Casadio C, Viale G, Liu J, Herlyn M, Godwin AK, Nuciforo PG and Cavallaro U: The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 68: 1110-1118, 2008. (Pubitemid 351272229)
17. Daponte A, Kostopoulou E, Kollia P, Papamichali R, Vanakara P, Hadjichristodoulou C, Nakou M, Samara S, Koukoulis G and Messinis IE: L1 (CAM) (CD171) in ovarian serous neoplasms. Eur J Gynaecol Oncol 29: 26-30, 2008. (Pubitemid 351344757)
18. Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S, Zentgraf H, Fogel M and Altevogt DP: ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 17: 292-294, 2003.
19. Stoeck A, Gast D, Sanderson MP, Issa Y, Gutwein P and Altevogt P: L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol 104: 461-469, 2007. (Pubitemid 46156956)
20. Knogler K, Grunberg J, Zimmermann K, Cohrs S, Honer M, Ametamey S, Altevogt P, Fogel M, Schubiger PA and Novak-Hofer I: Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res 13: 603-611, 2007. (Pubitemid 46225367)
21. Primiano T, Baig M, Maliyekkel A, Chang BD, Fellars S, Sadhu J, Axenovich SA, Holzmayer TA and Roninson IB: Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cell 4: 41-53, 2003. (Pubitemid 36904160)
22. De Angelis E, Brummendorf T, Cheng L, Lemmon V and Kenwrick S: Alternative use of a mini exon of the L1 gene affects L1 binding to neural ligands. J Biol Chem 276: 32738-32742, 2001. (Pubitemid 37384718)
23. Lee KR,Tavassoli FA,Prat J et al: Surface epithelial-stromal tumours. In: World Health Organization Classification of Tumours. Tumours of the Breast and Female Genital Organs. Lyon, IARC Press, pp. 117-145, 2003.
24. Silverberg SG: Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 19: 7-15, 2000. (Pubitemid 30010638)
25. Kallunki P, Edelman GM and Jones FS: Tissue-specific expression of the L1 cell adhesion molecule is modulated by the neural restrictive silencer element. J Cell Biol 138: 1343-1354, 1997. (Pubitemid 27415060)
26. Sebens MS, Werbing V, Sipos B, Debus MA, Witt M, Grossmann M, Leisner D, Kotteritzsch J, Kappes H, Kloppel G, Altevogt P, Folsch UR and Schafer H: Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 26: 2759-2768, 2007. (Pubitemid 46663831)
27. Frey UH, Adamzik M, Kottenberg-Assenmacher E, Jakob H, Manthey I, Broecker-Preuss M, Bergmann L, Heusch G, Siffert W, Peters J and Leineweber K: A novel functional haplotype in the human GNAS gene alters G{alpha}s expression, responsiveness to {beta}-adrenoceptor stimulation, and perioperative cardiac performance. Eur Heart J, 2009.
28. Lamba J, Lamba V, Strom S, Venkataramanan R and Schuetz E: Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR112 and their association with CYP3A4 expression. Drug Metab Dispos 36: 169-181, 2008.